Ivascular has announced the product range extension of its self-expandable stent, iVolution, to 200mm length, in various diameters.
Ivolution is a nitinol endovascular stent, combining high flexibility and conformability, together with increased radial strength. Its mechanical properties have been independently evaluated by the Paris Institute of Technology.
Lluis Duocastella, iVascular CEO said: “The addition of the 200mm iVolution to the iVascular portfolio, is a major step to improve therapy in the most complex indications such as TASC C and D femoropopliteal lesions. We are excited to provide such new references to physicians, without any compromise on the French size compatibility, stent features or ease of use”.